Fiasp insulin to remain on the Pharmaceutical Benefits Scheme 18 September 2023 Diabetes Australia has welcomed the announcement by Minister for Health and Aged Care, Hon Mark Butler MP, that Fiasp insulin will continue to be available on the Pharmaceutical Benefits Scheme (PBS) from 1 October 2023. Minister Butler has announced the new listing of Fiasp Penfill which contains the same insulin (fast acting insulin aspart) in the same volume as the previously PBS listed Fiasp FlexTouch, but is delivered through a different device. This follows the announced removal by the supplier of the products Fiasp and Fiasp FlexTouch (forms of fast acting insulin aspart) from the PBS earlier this year. Over the last 6 months the Government has negotiated with drug sponsor Novo Nordisk to list Fiasp Penfill as a new form of the fast acting insulin aspart. During this period, Diabetes Australia, along with our unifying health partner organisations the Australian Diabetes Society and the Australian Diabetes Educators Association, has been advocating to represent the voice of the community to both Government and Fiasp manufacturer, Novo Nordisk. This announcement will bring significant relief for the 15,000 Australians living with diabetes who use Fiasp. Diabetes Australia Group CEO Justine Cain applauded Minister Butler’s intervention which allows ongoing access to the insulin used by around 15,000 Australians living with diabetes. “Minister Butler has demonstrated that the Albanese Government understands how important it is to give people living with diabetes access to the affordable medicines and technologies they need to manage the condition,” Ms Cain said. “Diabetes is a demanding and complicated condition that needs constant monitoring. “Australians living with diabetes need access to the best available insulins and medicines, at affordable prices, to have their best quality of life and reduce the impact of diabetes-related complications,” Ms Cain said. Read Minister Butler’s media release.
Media releases 23 September 2024 Groundbreaking CDE qualification for Aboriginal Health Practitioner For the first time, an Aboriginal Health Practitioner has qualified as a Credentialled Diabetes Educator (CDE). Louise Gilbey, who lives... Continue Reading
Blog 31 July 2024 Stephanie’s a golden girl already! Stephanie Ratcliffe, diagnosed with type 1 diabetes when she was six, is at the Paris Olympics preparing to represent Australia in the Hammer Throw. Her Dad, David Ratcliffe, is as proud as any father could be. Continue Reading
Blog 12 July 2024 Melanie & Andrew’s story Melanie didn’t anticipate her son Andrew’s type 1 diabetes diagnosis at 7 years of age. “We didn’t have the right level of coverage for an insulin pump." Continue Reading